Humanosphere: Malaria vaccine disappoints, shifts strategy for eradication
In a guest post, science writer Robert Fortner discusses recently released data on an experimental malaria vaccine, as well as efforts to eradicate the disease (4/24).

MEASURE Evaluation: Invest in the Future: Strengthen Malaria Programs with Gender Data
“…On April 25, World Malaria Day, MEASURE Evaluation encourages all public health workers and decision makers to consider the impact of gender on treating one of the world’s worst killers and to make the commitment to increase and improve gender-related data collection to assist in strategy and planning for effective malaria prevention and response…” (4/24).

U.S. Global Leadership Coalition: Together we can invest in the future and #DefeatMalaria
Nick Moenck, communications associate at the U.S. Global Leadership Coalition, highlights the malaria eradication efforts of USAID, the President’s Malaria Initiative, and USGLC members including ExxonMobil, RTI International, PSI, and the U.N. Foundation (4/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.